A Rare Presentation of Levetiracetam-Induced Torsades De Pointes.
| Autor: | Mann H; Internal Medicine, One Brooklyn Health System Interfaith Medical Center, Brooklyn, USA., Kusayev J; Medicine, New York Medical College, Valhalla, USA., Pandey S; Internal Medicine, One Brooklyn Health System Interfaith Medical Center, Brooklyn, USA., Aryal B; Internal Medicine, One Brooklyn Health System Interfaith Medical Center, Brooklyn, USA., Solaimanzadeh I; Internal Medicine, One Brooklyn Health System Interfaith Medical Center, Brooklyn, USA. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Cureus [Cureus] 2023 Jun 23; Vol. 15 (6), pp. e40866. Date of Electronic Publication: 2023 Jun 23 (Print Publication: 2023). |
| DOI: | 10.7759/cureus.40866 |
| Abstrakt: | Torsades de pointes occurs in the presence of a prolonged QTc interval, which has many congenital and acquired causes. Levetiracetam is a widely used anti-epileptic medication secondary to its favorable safety profile. We present a rare case of a 59-year-old male who developed torsades de pointes and cardiac arrest after levetiracetam administration. To our knowledge, there is only one other case report documenting torsades de pointes after levetiracetam administration, and our case report will be the first documenting cardiac arrest after levetiracetam administration. Competing Interests: The authors have declared that no competing interests exist. (Copyright © 2023, Mann et al.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|